Pharmacological therapy of sialorrhea in patients with motor neuron disease

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 105, Issue 3, 2005, Pages 19-22

  Levitsky, G N ^a   Alekhin, A V ^a   Serdyuk, A V ^a   Morgunova, M S ^a   Koneva, O N ^a   Skvortsova, V I ^a  

^a NONE

Author keywords

Amithryptiline; Dysport; Motor neuron disease; Palliative therapy; Sialorrhea

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; AMITRIPTYLINE; BOTULINUM TOXIN A; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECONOMICS; FEMALE; HUMAN; HYPERSALIVATION; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; PALLIATIVE THERAPY; SALIVA; SALIVARY GLAND; SCINTISCANNING; SECRETION; TIME;

ADRENERGIC UPTAKE INHIBITORS; AGED; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; PALLIATIVE CARE; SALIVA; SALIVARY GLANDS; SIALORRHEA; TIME FACTORS;

EID: 17844407914     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Beck M., Giess R., Magnus T. et al. Progressive sudomotor dysfunction in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiat 2002; 73: 1: 68-70.
2. Brooks B.R., Miller R.G., Swash M. et al. "Current Issues in ALS Therapeutic Trials" Workshop Contributors (1998). El Escorial Revisted: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. http://www.wfnals.org/Articles/elescorial1998.html (The WFN/ALS Website).
3. Cederbaum J.M., Stambler N. Performance of Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 1997; 152: Suppl 1: S1-9.
4. Ethunandan M., Macpherson D.W. Persistent drooling: treatment by bilateral submandibular duct transposition and simultaneous sublingual gland excision. Ann K Coll Surg Engl 1989; 80: 279-282.
5. Giess R., Naumann M., Werner E. et al. Injections off botulinum toxin A into the salivary glands improve sialorrhea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiat 2000; 69: 121-123.
6. Miller R.G., Bradley W.G., Gelinal D.F. et al. Amyotrophic lateral sclerosis. Continuum 2002; 8: 4: 1-227.
7. Naumann M., Jost W.H., Toyka K.V. Botulinum toxin in treatment of neurological disorders of the autonomic nervous system. Arch Neurol 1999; 56: 914-916.
8. Newrick P.G., Langton Hewer K. Motor neuron disease: can we do better? A study of 42 patients. BMJ 1984; 289: 539-542.
9. Norris F.H. Onset, natural history and prognosis of adult motor neuron disease. J Neurol Sci 1993; 118: 48-55.
10. Winterholler M.G.M., Erbguth F.J., Wolf S. et al. Botulinum toxin for the treatment of sialorrhea in ALS: serious side effects of a transductal approach. J Neurol Neurosurg Psychiat 2001; 70: 3: 417-418.